Sotirios K. Karathanasis

National Institutes of Health — United States

Medicine · Health Sciences

43h-index7.5kcitations113works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lipoproteins and Cardiovascular Health(21), Cholesterol and Lipid Metabolism(20), Peroxisome Proliferator-Activated Receptors(16), Diabetes, Cardiovascular Risks, and Lipoproteins(15), Drug Transport and Resistance Mechanisms(14)

Publications113 total

Relationship of Soluble Lectin‐Like Low‐Density Lipoprotein Receptor‐1 (sLOX‐1) With Inflammation and Coronary Plaque Progression in Psoriasis
Journal of the American Heart Association·2023· 4 citedOpen Access
Phenotypic changes in low-density lipoprotein particles as markers of adverse clinical outcomes in COVID-19
Molecular Genetics and Metabolism·2023· 9 citedOpen Access
Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results
Journal of the American Heart Association·2023· 19 citedOpen Access
<b>Structural and functional studies of a monoclonal antibody blocking LOX-1</b>
Figshare·2023Open Access
A Simple Fluorescent Cholesterol Labeling Method to Cryoprotect and Detect Plasma Lipoprotein-X
Biology·2022· 5 citedOpen Access
A new phenotypic classification system for dyslipidemias based on the standard lipid panel
Lipids in Health and Disease·2021· 21 citedOpen Access
A New Phenotypic Classification System for Dyslipidemias Based on the Standard Lipid Panel
2021· 1 citedOpen Access
MEDI6012: Recombinant Human Lecithin Cholesterol Acyltransferase, High‐Density Lipoprotein, and Low‐Density Lipoprotein Receptor–Mediated Reverse Cholesterol Transport
Journal of the American Heart Association·2021· 27 citedOpen Access
THE SAFETY AND EFFICACY OF SINGLE AND MULTIPLE ASCENDING DOSES OF MEDI6570 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS
Journal of the American College of Cardiology·2021· 1 cited
Blocking endothelial lipase with monoclonal antibody MEDI5884 durably increases high density lipoprotein in nonhuman primates and in a phase 1 trial
Science Translational Medicine·2021· 24 cited
Recombinant human lecithin-cholesterol acyltransferase in patients with atherosclerosis: phase 2a primary results and phase 2b design
European Heart Journal - Cardiovascular Pharmacotherapy·2021· 21 citedOpen Access
Role of LOX-1 (Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1) as a Cardiovascular Risk Predictor
Arteriosclerosis Thrombosis and Vascular Biology·2020· 138 citedOpen Access
COVID‐19—Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches
The FASEB Journal·2020· 159 citedOpen Access
Lecithin:cholesterol acyltransferase: symposium on 50 years of biomedical research from its discovery to latest findings
Journal of Lipid Research·2020· 35 citedOpen Access
LOX-1: A potential driver of cardiovascular risk in SLE patients
PLoS ONE·2020· 27 citedOpen Access
Effects of intramyocardial injection of human neonatal cardiac progenitor cells on cardiac function, circulating biomarkers and scar size post myocardial infarction in nude rats
Journal of Molecular and Cellular Cardiology·2020
Novel lecithin:cholesterol acyltransferase-based therapeutic approaches
Current Opinion in Lipidology·2020· 24 citedOpen Access
LCAT protects against Lipoprotein‐X formation in a murine model of drug‐induced intrahepatic cholestasis
Pharmacology Research & Perspectives·2019· 8 citedOpen Access
Human Relaxin‐2 Fusion Protein Treatment Prevents and Reverses Isoproterenol‐Induced Hypertrophy and Fibrosis in Mouse Heart
Journal of the American Heart Association·2019· 28 citedOpen Access
Association Between Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 and Coronary Artery Disease in Psoriasis
JAMA Dermatology·2019· 26 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Vassilis I. Zannis(9), Jan L. Breslow(6), Sohail Malik(5), John D. McPherson(4), Alan T. Remaley(4), Douglas C. Harnish(4), John A. A. Ladias(3), J L Breslow(3), Argiris Efstratiadis(3), Robert J. Schmidt(3), Youyan Zhang(3), Thomas P. Beyer(3), Robert L. Panek(3), Marshall S. Scicchitano(3), Russell L. Widom(3), G.A.P. Bruns(2), Scott Zeitlin(2), William R. Bensch(2), Patrick I. Eacho(2), Tae‐Sik Park(2)